Health News - Diabetic Life. Learn about Juvenile Diabetes, Heart Disease, Glucose testing and much more.
A Member of the Healthscout Network
 Printer Friendly  Send to a Friend

Heart Screening Not Effective for Type 2 Diabetics

Imaging test doesn't single out those at high risk of trouble, study found

By Ed Edelson
HealthDay Reporter

TUESDAY, April 14 (HealthDay News) -- Routine screening for coronary artery disease is of no value for adults with diabetes who have no symptoms of heart problems, a new study finds.

Screening is expensive, at $1,000 per test. But the study of 1,123 people with type 2 diabetes who had no symptoms of heart disease did not identify those at high risk of developing cardiac problems.

Advertisement
Related Stories
 border=
Increasing Soda Consumption Fuels Rise in Diabetes, Heart Disease
Processed Meat May Harm the Heart
More Info Needed on Problems With Insulin Pumps
Related Videos
 border=
Reversing Nerve Damage
Monitoring Diabetes
Patients And Doctors Discuss The I-Port
Related Slides
 border=
Diabetes
Thyroid Disease
Diabetic Retinopathy
Related Encyclopedia
 border=
Addison's Disease
Carcinoid Syndrome
Congenital Adrenal Hyperplasia


The findings were published in the April 15 issue of the Journal of the American Medical Association -- an issue devoted to diabetes.

"It was a surprise," Dr. Lawrence H. Young, professor of medicine at Yale University and a leader of the study, said of the results. "There is no question that coronary artery disease is still a major concern in patients with type 2 diabetes."

While the study did identify a small group of people at increased risk of coronary artery disease, "in the overall population, patients who were screened did not have a better outcome specifically in terms of heart attacks and cardiac death," Young said.

For doctors managing people with type 2 diabetes, "the implication is that a routine patient who is doing well, on state-of-the-art medication such as cholesterol-lowering drugs, aspirin and diabetes therapy, need not be subjected to specialized stress testing," he said. "But patients who have any symptoms of heart disease need to be screened."

The people in the study were randomly assigned to have either a sophisticated screening test -- adenosine-stress radionuclide myocardial perfusion imaging -- or no test. In a follow-up period averaging 4.8 years, 2.7 percent of the people in the screened group had heart attacks or died of cardiac disease, compared to 3.0 percent of those who were not screened.

Many of the people in the study had well-known risk factors for heart disease, Young noted. "In our study, most patients were overweight, and many had other risk factors such as hypertension [high blood pressure] and high cholesterol," he said. "But those were treated well by the primary-care physicians."

Diabetics who should be screened are those with a family history of heart disease or have symptoms of cardiac problems, such as the chest pain called angina, feeling of tightness and heaviness in the chest, and unexplained shortness of breath on exertion, Young said.

One possible reason for the negative finding in the study is that plans for the trial were made eight or nine years ago, and preventive measures have improved since then, said Dr. Steven D. Wittlin, professor of medicine at the University of Rochester in New York, and a member of the study group. The incidence of heart problems found in the study was lower than had been expected, he said.

"During that time, a lot more people have gone on aspirin and ACE inhibitors and other drugs, and that may account for the low rate," Wittlin said.

There are two major findings in the study, he said. "On the one hand, it verifies that people with type 2 diabetes who are middle-aged and have a positive stress test have an increased risk of a cardiac event," Wittlin said. "But the event rate was low enough so that it does not appear to be cost-effective to routinely screen patients with a nuclear stress test."

More information

The American Heart Association describes the role of diabetes in heart disease.

SOURCES: Lawrence H. Young, M.D., professor of medicine, Yale University, New Haven, Conn.; Steven D. Wittlin, M.D., professor of medicine, University of Rochester, N.Y.; April 15, 2009, Journal of the American Medical Association

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 4/14/2009



Disclaimer: The information provided on this website is for educational purposes only and does not serve as a replacement for care provided by your own personal health care team. This website does not render or provide medical advice, and no individual should make any medical decisions or change their health behavior based on information provided here. All pertinent content provided on this website should be discussed with your personal physician to evaluate whether it has any relevance to or impact on your specific condition. Reliance on any information provided by this website is solely at your own risk.


Mar 11, 2010
Home
Search
Powered By HealthLine
New! For timely and trustworth health information, expert advice and much more, visit Diabetes Connections
Patient Guide
News
Health Videos
Health Encyclopedia
Health News Archive
Affiliate Information
HealthScout Network
Contact Us
Newsletters
Privacy Policy
Terms of Use

We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service  

To find more information on specific conditions, please visit our partner sites: